Advance Agrolife IPO Proceeds Utilization Report for Q1 FY27 Shows No Deviations
Advance Agrolife Limited's Q1 FY27 monitoring report confirms ₹192.84 crore IPO proceeds were utilized as disclosed, with no material deviations. ₹67.50 crore was used for working capital, and ₹0.29 crore for issue expenses. ₹67.79 crore remains unutilized. The report was issued by CARE Ratings Limited.
This is a standard regulatory filing detailing the use of funds from a past IPO, with no new financial performance or future guidance provided that would significantly impact the company's valuation or operations.
The report is a routine monitoring agency submission confirming adherence to the utilization plan of IPO proceeds, with no significant positive or negative developments.
Advance Agrolife Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of proceeds from its Initial Public Offering (IPO). The report, issued by CARE Ratings Limited, confirms that the company has utilized the IPO funds amounting to ₹192.84 crore in accordance with the disclosures made in the offer document. There have been no material deviations from the planned expenditures.
The company's IPO, which raised ₹192.84 crore through equity shares, was conducted between September 30, 2025, and October 03, 2025. The primary objects of the issue included funding working capital requirements (₹135.00 crore), general corporate purposes (₹34.08 crore), and issue-related expenses (₹23.76 crore).
For the quarter ended June 30, 2026, ₹67.50 crore was utilized towards working capital requirements. This amount was transferred from a fixed deposit redeemed in the current account, which was subsequently used for payments to suppliers for raw materials and to meet statutory obligations like income tax. The report notes the commingling of funds in the cash credit account and states reliance on management declarations and CA certificates for fund utilization. General corporate purposes saw no utilization during the quarter, with ₹34.08 crore remaining unutilized. Issue-related expenses accounted for ₹0.29 crore utilized during the quarter, with ₹0.05 crore spent and ₹0.24 crore taken as reimbursement.
Overall, as of June 30, 2026, the total utilization stands at ₹125.05 crore, with ₹67.79 crore remaining unutilized. The report also confirms that there are no delays in the implementation of the objects, with working capital requirements and general corporate purposes planned for FY26 and FY27, and issue-related expenses for FY27.
What to do with a filing like this
Advance Agrolife Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Advance Agrolife Limited. Read the original for the full detail.